Patients with mild to moderate dry eye disease will be randomized to receive either NovaTears® or Hydrabak® eye drops as control.

Inclusion Criteria:

• Men and women aged over 18 years
• History of dry eye disease for at least 3 months before the screening visit
• Be able and willing to follow instructions, including participation in all study assessments and visits
• Signed and dated written informed consent

Exclusion Criteria:

• Have any clinically significant slit-lamp findings at the screening visit that may include trauma, Steven Johnson syndrome, and/or in the opinion of the investigator may interfere with study parameters
• Participation in a clinical trial in the 4 weeks preceding the before the screening visit
• Active ocular allergies or ocular allergies that are expected to be active during the study period
• Pregnancy, planned pregnancy or lactating
• Known hypersensitivity to any component of the study medication
• Any medical or surgical history, disorder or disease such as acute or chronic severe organic disease